GGrantIndex
Sort

23,748 grants matching melanoma

The role of antigen-specific CD4+ T cells during immunity to established tumors

$161,730
Paul Andrew Antony · University Of Maryland Baltimore · K22 · FY2008 · CA

Immunomodulation in melanoma: Toll like receptors and therapeutic vaccines

$161,730
Noah A Craft · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · K22 · FY2008 · CA

Development of Novel Markers for Melanoma Progression

$161,730
Byungwoo Ryu · Johns Hopkins University · K01 · FY2007 · CA

The role of antigen-specific CD4+ T cells during immunity to established tumors

$161,730
Paul Andrew Antony · University Of Maryland Baltimore · K22 · FY2009 · CA

Immunomodulation in melanoma: Toll like receptors and therapeutic vaccines

$161,730
Noah A Craft · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · K22 · FY2009 · CA

Immunomodulation in melanoma: Toll like receptors and therapeutic vaccines

$161,730
Noah A Craft · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · K22 · FY2010 · CA

Pathology Core

$161,646
David E E Elder · Wistar Institute · P01 · FY2009 · CA

SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS

$161,615
University Of Oklahoma Hlth Sciences Ctr · U10 · FY2000 · CA

Immunogene Therapy of Mesothelin Expressing Tumors Using Engineered T Cells

$161,613
Carl H. June · University Of Pennsylvania · P01 · FY2014 · CA

Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF

$161,500
Dario Marchetti · University Of New Mexico Health Scis Ctr · R01 · FY2024 · CA

Targeting metabolic checkpoints in the tumor microenvironment to boost efficacy of anti-CTLA-4

$161,494
Lewis Zhichang Shi · University Of Alabama At Birmingham · R21 · FY2020 · CA

Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance

$161,494
John M Parant · University Of Alabama At Birmingham · R21 · FY2018 · CA

Overcoming immune checkpoint inhibition with therapeutic plasma exchange and radiotherapy in melanoma

$161,411
Sean S Park · Mayo Clinic Rochester · R21 · FY2022 · CA

Targeting Lipid Metabolism in the Tumor Microenvironment

$161,373
Ashani T Weeraratna · Wistar Institute · P01 · FY2022 · CA

Core C - Melanoma Screening and Stratification

$161,358
David F Stern · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2016 · CA

PD-1 Blockade and Neoantigen-Specific T Cell Immunity

$161,348
Gerald P Linette · University Of Pennsylvania · R21 · FY2018 · CA

Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer

$161,259
Scott J Antonia · H. Lee Moffitt Cancer Ctr & Res Inst · K24 · FY2008 · CA

Investigating a novel shelterin-associated protein complex in telomere protection

$161,035
Weidong Wang · National Institute On Aging · ZIA · FY2023 · AG

DORMANCY VERSUS PROGRESSION OF HUMAN PRIMARY MELANOMA

$161,012
Sunnybrook &Women'S Coll Hlth Scis Ctr · R01 · FY2001 · CA

Multimodal multifocal confocal Raman and phase microscopy with enhanced resolution

$160,968
Peter T. So · Massachusetts Institute Of Technology · P41 · FY2020 · EB

INDUCTION OF MELANOMA WITH UV-A

$160,912
University Of New Mexico · R01 · FY2000 · CA

Project 4: Multiplatform analysis on melanoma molecular subtypes and patient survival outcome

$160,910
Ronglai Shen · University Of New Mexico Health Scis Ctr · P01 · FY2021 · CA

Evaluating the anti-tumor effects of novel curcumin analogs in melanoma

$160,869
Gregory B. Lesinski · Ohio State University · R21 · FY2011 · CA

Differential Regulation of Tumor Invasion by RSK Family Isoforms

$160,868
Michelle Christine Mendoza · University Of Utah · R21 · FY2019 · CA

Genomic Sunlight Dosimeters for Melanoma Prevention

$160,848
Douglas E Brash · Yale University · P50 · FY2017 · CA